1. A deep intronic variant in LDLR causing familial hypercholesterolemia: Time to widen the scope?. (August 2018) Authors: Reeskamp, L.F.; Hartgers, M.L.; Peter, J.; Dallinga-Thie, G.M.; Grefhorst, A.; Zuurbier, L.C.A.; Defesche, J.C.; Hovingh, G.K. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An exploratory analysis of causes for extreme LDL-C levels in patients not carrying variants in genes causing familial hypercholesterolemia. (December 2020) Authors: Tromp, T.; Reeskamp, L.F.; Hartgers, M.; Grefhorst, A.; Zuurbier, L.; Defesche, J.C.; Hovingh, K. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Angiopoietin-like 3 (ANGPTL3) resides on HDL and LDL with the latter form having the highest lipase inhibitory activity. (August 2022) Authors: Tromp, T.R.; Reeskamp, L.F.; Langenkamp, M.; Levels, J.H.M.; Hoekstra, M.; Hovingh, G.K.; Grefhorst, A. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Circulating micro-RNAs implicated in lipoprotein metabolism in patients with familial hypercholesterolemia of unknown origin. (August 2022) Authors: Tromp, T.R.; Reeskamp, L.F.; Grefhorst, A.; Stroes, E.S.; Hovingh, G.K. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evinacumab markedly reduces low-density lipoprotein cholesterol in adolescent patients with homozygous familial hypercholesterolemia. (August 2021) Authors: Reeskamp, L.F.; Greber-Platzer, S.; Saheb, S.; Stefanutti, C.; Stroes, E.S.G.; Ali, S.; Banerjee, P.; Pordy, R.; Zhao, J.; Raal, F.J. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Genetic testing for familial hypercholesterolemia using low-cost high-throughput microarray-based genotyping. (August 2022) Authors: Ibrahim, S.; Van Rooij, J.; Defesche, J.C.; Sedaghatikhayat, B.; Hovingh, G.K.; Uitterlinden, A.; Stroes, E.S.; Reeskamp, L.F. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Polygenic risk for future coronary artery disease events in familial hypercholesterolemia. (August 2022) Authors: Reeskamp, L.F.; Shim, I.; Dron, J.; Ibrahim, S.; Tromp, T.R.; Patel, A.P.; Hutten, B.A.; Stroes, E.S.; Hovingh, G.K.; Khera, A.V. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Statins Reduce Hepatic Angptl3 Expression And Secretion, Likely By Interfering With Lxr-Mediated Transcription. (August 2019) Authors: Grefhorst, A.; Reeskamp, L.F.; Huijgen, R.; Hovingh, G.K. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The efficacy and safety of evinacumab in homozygous familial hypercholesterolaemia (HoFH) patients with little to no low-density lipoprotein receptor (LDLR) activity. (December 2020) Authors: Raal, F.J.; Rosenson, R.S.; Reeskamp, L.F.; Kastelein, J.J.; Baum, S.; Ali, S.; Banerjee, P.; Chan, K.-C.; Gipe, D.A.; Pordy, R.; Gaudet, D. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗